Publications

Journal Article Epublish 1 citations
Electronic publication date
October 26, 2024

View on Pubmed.gov 39455662 | View on doi.org 10.1038/s41598-...

Circadian rhythm genes contribute to the prognosis prediction and potential therapeutic target in gastric cancer.

Search for publications in this journal Sci Rep - 14(1):25426

  • Chao Zhang

    Search for this expert
    1
  • Wen Yin

    Search for this expert
    1
  • Li-Ping Yuan

    Search for this expert
    1
  • Li-Jun Xiao

    Search for this expert
    1
  • Jing Yu 2
  • Wan-Meng Xiao

    Search for this expert
    1
  • Gang Luo 1
  • Ming-Ming Deng

    Search for this expert
    1
  • Sha Liu 1
  • Mu-Han Lü

    Search for this expert
    3

Abstract

The role of circadian rhythm genes (CRGs) in gastric cancer (GC) is poorly understood. This study aimed to develop a CRG signature to improve understanding of prognosis and immunotherapy responses in GC patients. We integrated the The Cancer Genome Atlas-Stomach adenocarcinoma (TCGA-STAD) dataset with CRGs to develop a prognostic signature for GC. The signature's predictive ability was validated using Kaplan-Meier and ROC curves. The CIBERSORT algorithm evaluated immune cell proportions, and tumor immune dysfunction and exclusion score, as well as immune phenotype score, determined the response to immunotherapy for STAD patients. Finally, we assessed signature genes expression using real-time quantitative polymerase chain reaction. We developed a 4-CRG signature for STAD, demonstrating accurate prognostic ability. The low-risk group showed increased B cell memory and CD8 + T cells, and decreased M2 Macrophages compared to the high-risk group. Patients in the low-risk group had a higher likelihood of benefiting from immunotherapy. Additionally, gastric cancer tissues exhibited elevated expression of OPN3 and decreased expression of TP53 compared to adjacent tissue. This study successfully established a prognostic signature for CRGs, accurately predicting prognosis and immunotherapeutic response among STAD patients, providing insights for the development of personalized therapeutic strategies for these patients.

References

Front Immunol. 2024 Jan 29;15:1324959

Prog Neuropsychopharmacol Biol Psychiatry. 2023 Apr 20;123:110721

Mod Pathol. 2024 Feb;37(2):100403

Nat Rev Immunol. 2015 Nov;15(11):669-82

Cited by 1 citations (total)

Journal Article Review

Unravelling the link between circadian clock genes and brain tumors: From pathological disruptions to potential therapeutic interventions.

Electronic publication date June 11, 2025

Search for publications in this journal Front Pharmacol

Amirah Albaqami

The circadian clock is present in nearly all tissues (including glial cells), which play crucial roles in brain functions and...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances

Copyright

© 2024. The Author(s).